Cargando…
Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial
BACKGROUND: Low-dose aspirin (LDA) has been proposed as a safe and inexpensive prophylactic agent. Studies in European/Western populations have shown promising results indicating that LDA can reduce the occurrence of pre-eclampsia (PE) in women with identifiable risk factors. However, few controlled...
Autores principales: | Lin, Li, Zhu, Yuchun, Li, Boya, Yang, Huixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218975/ https://www.ncbi.nlm.nih.gov/pubmed/30400937 http://dx.doi.org/10.1186/s13063-018-2970-3 |
Ejemplares similares
-
Low-dose aspirin in the prevention of pre-eclampsia in China: postpartum hemorrhage in subgroups of women according to their characteristics and potential bleeding risk
por: Chen, Jiahui, et al.
Publicado: (2023) -
The role of low-dose aspirin in the prevention of pre-eclampsia
por: Akhigbe, R. E.
Publicado: (2014) -
Application of low dose aspirin in pre-eclampsia
por: Ren, Yu, et al.
Publicado: (2023) -
Towards the APPEC strategy
por: Linde, Frank
Publicado: (2016) -
PROVE—Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
por: Bergman, Lina, et al.
Publicado: (2021)